Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Alberto Espino is active.

Publication


Featured researches published by Alberto Espino.


World Journal of Gastroenterology | 2014

Management of Helicobacter pylori infection in Latin America: a Delphi technique-based consensus.

Antonio Rollan; Juan Pablo Arab; M. Constanza Camargo; Roberto Candia; Paul R. Harris; Catterina Ferreccio; Charles S. Rabkin; Juan Cristóbal Gana; Pablo Cortés; Rolando Herrero; Luisa Durán; Apolinaria García; Claudio Toledo; Alberto Espino; Nicole Lustig; Alberto Sarfatis; Catalina Figueroa; Javier Torres; Arnoldo Riquelme

AIM To optimize diagnosis and treatment guidelines for this geographic region, a panel of gastroenterologists, epidemiologists, and basic scientists carried out a structured evaluation of available literature. METHODS Relevant questions were distributed among the experts, who generated draft statements for consideration by the entire panel. A modified three-round Delphi technique method was used to reach consensus. Critical input was also obtained from representatives of the concerned medical community. The quality of the evidence and level of recommendation supporting each statement was graded according to United States Preventive Services Task Force criteria. RESULTS A group of ten experts was established. The survey included 15 open-ended questions that were distributed among the experts, who assessed the articles associated with each question. The levels of agreement achieved by the panel were 50% in the first round, 73.3% in the second round and 100% in the third round. Main consensus recommendations included: (1) when available, urea breath and stool antigen test (HpSA) should be used for non-invasive diagnosis; (2) detect and eradicate Helicobacter pylori (H. pylori) in all gastroscopy patients to decrease risk of peptic ulcer disease, prevent o retard progression in patients with preneoplastic lesions, and to prevent recurrence in patients treated for gastric cancer; (3) further investigate implementation issues and health outcomes of H. pylori eradication for primary prevention of gastric cancer in high-risk populations; (4) prescribe standard 14-d triple therapy or sequential therapy for first-line treatment; (5) routinely assess eradication success post-treatment in clinical settings; and (6) select second- and third-line therapies according to antibiotic susceptibility testing. CONCLUSION These achievable steps toward better region-specific management can be expected to improve clinical health outcomes.


Revista Medica De Chile | 2010

[Helicobacter pylori infection in symptomatic patients with benign gastroduodenal diseases: analysis of 5.664 cases].

Juan Pablo Ortega; Alberto Espino; Alfonso Calvo B; Patricia Verdugo; Martha Pruyas; Eva Nilsen V; Luis Villarroel; Oslando Padilla; Arnoldo Riquelme; Antonio Rollán

UNLABELLED Infection with Helicobacter pylori (H. pylori) is highly prevalent in Chile, but there are no systematic studies in patients with upper gastrointestinal symptoms. AIM To determine the prevalence of H. pylori infection, according to age, gender and endoscopic pathology in a large sample of patients. METHODS We studied 7,893 symptomatic patients submitted to upper gastrointestinal endoscopy between July 1996 and December 2003 in the context of a screening program of gastric cancer in a high risk population. H. pylori infection was determined by rapid urease test (RUT) in antral mucosa. We excluded 158 patients with gastric cancer (2%) and 2,071 patients without RUT. RESULTS We included 5,664 patients, mean age 50.7 +/- 13.9 years, women 72.1%. Endoscopic diagnoses were normal in 59.3%, erosive esophagitis in 20%, gastric ulcer (GU) in 8.1%, duodenal ulcer (DU) in 6.4%, and erosive gastropathy in 6.2%. RUT was positive in 78% of patients. After adjusting for age and sex and with respect to patients with normal endoscopy, frequency of H. pylori infection was 86.6% in DU (OR 2.1, 95% CI 1.5-2.8, p < 0.001); 81.4% in GU (OR 1.8, 95% CI 1.4-2.4; p < 0.001 ); 79.9% in erosive gastropathy (OR 1.4, 95% CI 1.03-1.8; p = 0.03) and 77.4% in erosive esophagitis (OR 1.1, 95% CI: 0.9-1.3; p = NS). The probability of H. pylori infection decreased significantly with age, more markedly in men with normal endoscopy. CONCLUSIONS Prevalence of H. pylori infection is very high in symptomatic Chilean patients and even higher in those with gastroduodenal ulcer or erosions, while in patients with erosive esophagitis is similar to those with normal endoscopy. The frequency of infection decreases with age, probably as a consequence of rising frequency of gastric mucosal atrophy.


Revista Medica De Chile | 2011

Encuesta nacional online aplicada en pacientes con enfermedad celíaca en Chile

Alberto Espino; Cecilia Castillo L.; Ernesto Guiraldes; Helga Santibáñez; Juan Francisco Miquel

BACKGROUND Celiac disease (CD) is an immune-mediated enteropathy triggered by the ingestion of gluten in genetically susceptible individuals. Its prevalence in Europe and the USA is 0.5 to 1%. AIM To analyze epidemiological aspects and degree of compliance with gluten-free diet (GFD) among Chilean individuals with CD. MATERIAL AND METHODS Subjects with confirmed or suspected CD were invited to answer an online survey published on the web at www.fundacionconvivir.cl. The answers were reinforced with a telephone interview. RESULTS The survey was answered by 1212 subjects (79% females). Median age at diagnosis was 25.8 years (range 1 to 84 years), with a bimodal curve with two peaks at less than 3 years and at 20 to 40 years of age. The diagnosis was made only by serologic markers in 9%, only by intestinal biopsy in 17.5%, and by a combination of both methods in 70%o. Conditions associated with CD were reported by 30% > of subjects and 20% > had relatives with CD. The GFD was strictly adhered to by 70% >, occasionally by 27% > and never by 3% >. Seventy five percent of subjects with a strict adherence to GFD had a favorable clinical response compared with 42% > of those with incomplete or lack of adherence (odds ratio 4.0, 95% > confidence intervals 2.8-5.7p did not experience a clinical improvement despite a strict GFD, a finding which requires further study.


The Lancet Gastroenterology & Hepatology | 2018

Gastrointestinal tract involvement in Klippel–Trénaunay syndrome

Andrea Sepulveda; Humberto Soriano; Alberto Espino


Gastrointestinal Endoscopy | 2017

Use of N-acetylcysteine plus simethicone to improve mucosal visibility during upper GI endoscopy: a double-blind, randomized controlled trial

Hugo Monrroy; Jose Ignacio Vargas; Esteban Glasinovic; Roberto Candia; Emilio Azúa; Camila Gálvez; Camila Rojas; Natalia Cabrera; Josefa Vidaurre; Natalia Álvarez; Jessica González; Alberto Espino; Robinson G. Gonzalez; Adolfo Parra-Blanco


Gastroenterology | 2018

Sa1644 - High Prevalence of Autoimmune Gastropathy, Clinical Characteristics and Association with Hypothyroidism: Prospective Analisys of 921 Patients with Gastric Biopsies by Sydney Protocol

Jose Ignacio Vargas; Sara Maquilon; Javiera Torres; Santiago Revelo; Camila Vargas; Antonia Garcia-Huidobro; Josefina Castro; Roberto Candia; Robinson G. Gonzalez; Rene Baudrand; Alberto Espino


Gastrointestinal Endoscopy | 2017

Mo1203 Impact of the Staging of Gastritis With the Olga System for Risk Stratification in a Chilean Population With High Prevalence of Gastric Cancer

Jose Ignacio Vargas; Diego San Martin; Hugo Monrroy; Javiera Torres; Juan Carlos Roa; Carlos Jiménez; Natalia Cabrera; Gabriela Zepeda; Hugo Demandes; Josefa Vidaurre; Gonzalo Latorre; Camila Robles; Matias Jimenez; Jorge Flandez; Robinson G. Gonzalez; Roberto Candia; Alberto Espino; Arnoldo Riquelme


Gastrointestinal Endoscopy | 2017

Su1210 Epidemiology of Small Bowel Tumors: 16 Years of Experience at a Chilean University Center

Jorge Flandez; Rodrigo Cruz; Paula Calderon; Camila Aldana; Martin Vasquez; Rocio Andrade; Nicolás Jarufe; Jorge Martínez; Juan Francisco Guerra; María Elena Molina; Felipe Bellolio; Rodrigo Migueles; Jose Larach; Fernando Pimentel; Allan Sharp; Andrés Donoso; Ricardo Mejía; Javiera Torres; Ignacio Duarte; Jose Ignacio Vargas; Diego San Martin; Manuel Alvarez-Lobos; Robinson G. Gonzalez; Alberto Espino


Gastrointestinal Endoscopy | 2016

Mo2025 Safety And Efficacy of Hemospray® In Upper Gastrointestinal Bleeding: Experience In A Chilean Academic Hospital

Rodrigo Mansilla Vivar; Carlos Valenzuela; Robinson G. Gonzalez; Adolfo Parra-Blanco; Alberto Espino


Gastrointestinal Endoscopy | 2016

Tu1165 Endoscopic Therapy For Barrett's Esophagus: A Chilean Academic Hospital Experience

Rodrigo Mansilla Vivar; Robinson G. Gonzalez; Hugo Richter; Juan Carlos Roa; Javiera Torres; Javier Chahuan; Thomas Uslar; A Parra-Blanco; Alberto Espino

Collaboration


Dive into the Alberto Espino's collaboration.

Top Co-Authors

Avatar

Robinson G. Gonzalez

Pontifical Catholic University of Chile

View shared research outputs
Top Co-Authors

Avatar

Roberto Candia

Pontifical Catholic University of Chile

View shared research outputs
Top Co-Authors

Avatar

Javiera Torres

Pontifical Catholic University of Chile

View shared research outputs
Top Co-Authors

Avatar

Jose Ignacio Vargas

Pontifical Catholic University of Chile

View shared research outputs
Top Co-Authors

Avatar

Arnoldo Riquelme

Pontifical Catholic University of Chile

View shared research outputs
Top Co-Authors

Avatar

Manuel Alvarez-Lobos

Pontifical Catholic University of Chile

View shared research outputs
Top Co-Authors

Avatar

Allan Sharp

Pontifical Catholic University of Chile

View shared research outputs
Top Co-Authors

Avatar

Andrés Donoso

Pontifical Catholic University of Chile

View shared research outputs
Top Co-Authors

Avatar

Camila Robles

Pontifical Catholic University of Chile

View shared research outputs
Top Co-Authors

Avatar

Fernando Pimentel

Pontifical Catholic University of Chile

View shared research outputs
Researchain Logo
Decentralizing Knowledge